Dudediligence.

enGene Therapeutics Inc

ENGNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 810-QQuarterly report
  2. Sep 88-KResults of operations2.029.01
  3. Aug 118-KOther events8.019.01
  4. Jul 2213GPassive stake of 5% or more (13G), filed by Acorn Bioventures
  5. Jul 178-KRegulation FD disclosure7.019.01
  6. Jul 168-KOfficer or director change and Regulation FD disclosure5.027.019.01
  7. Jun 188-K/AOfficer or director change and exit or restructuring costs (amended)2.055.02
  8. Jun 1510-QQuarterly report
  9. Jun 158-KResults of operations and officer or director change2.022.055.027.018.019.01
  10. Jun 108-KShareholder vote5.079.01
  11. May 78-KOfficer or director change and Regulation FD disclosure5.027.018.019.01
  12. Apr 98-KBylaws or fiscal year changed and Regulation FD disclosure5.037.019.01
  13. Mar 9424B5Prospectus for an offering
  14. Mar 98-KMaterial agreement and end of a material agreement1.011.029.01
  15. Mar 910-QQuarterly report
  16. Mar 98-KResults of operations2.029.01
  17. Feb 19S-3Shelf registration
  18. Jan 218-KMaterial agreement and unregistered sale of shares1.012.033.029.01
  19. Jan 218-KRegulation FD disclosure7.019.01
  20. Dec 22, 202510-KAnnual report
  21. Dec 22, 20258-KResults of operations2.029.01
  22. Nov 14, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  23. Nov 14, 2025424B5Prospectus for an offering
  24. Nov 12, 2025424B5Prospectus for an offering
  25. Nov 12, 20258-KRegulation FD disclosure and other events7.018.019.01
  26. Oct 2, 20258-KOfficer or director change5.02
  27. Oct 2, 20258-K/AOfficer or director change (amended)5.02
  28. Sep 30, 20258-KRegulation FD disclosure7.019.01
  29. Sep 11, 202510-QQuarterly report
  30. Sep 11, 20258-KResults of operations2.029.01
  31. Sep 3, 20258-KRegulation FD disclosure and other events7.018.019.01
  32. Jul 8, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  33. Jun 12, 202510-QQuarterly report
  34. Jun 12, 20258-KResults of operations2.029.01
  35. Jun 10, 20258-KOfficer or director change and shareholder vote5.025.079.01
  36. Jun 9, 20258-KMaterial agreement and new debt or obligation1.012.039.01
  37. Jun 4, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  38. Mar 10, 202510-QQuarterly report
  39. Mar 10, 20258-KResults of operations2.029.01
  40. Dec 20, 20248-KMaterial agreement1.019.01
  41. Dec 20, 2024424B5Prospectus for an offering
  42. Dec 19, 202410-KAnnual report
  43. Dec 19, 20248-KMaterial agreement and results of operations1.012.022.039.01
  44. Nov 21, 2024424B3Prospectus for an offering
  45. Nov 21, 2024424B3Prospectus for an offering
  46. Nov 13, 2024S-3Shelf registration
  47. Nov 13, 2024S-3Shelf registration
  48. Oct 28, 2024424B3Prospectus for an offering
  49. Oct 25, 20248-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  50. Oct 21, 2024424B3Prospectus for an offering
  51. Oct 21, 20248-KOfficer or director change and Regulation FD disclosure5.027.018.019.01